Shangbay Capital

ShangBay Capital is a venture capital firm that brings investors access to best-in-class investments in the U.S. MedTech sector.

[Luminopia @luminopia]

https://t.co/XZq7IfydXo

[Shangbay Capital @ShangbayCapital]

https://t.co/p5DXzJAkFG

[Shangbay Capital @ShangbayCapital]

@PresidioMedical, a medical technology company developing a transformational Ultra Low-Frequency neuromodulation platform, has closed a $72 million Series C funding round. This round was led by Deerfield Management, existing investors, and joined by ShangBay Capital

[Luminopia @luminopia]

We’re thrilled to announce the close of a $16m Series A financing round, led by USVP. The capital will allow us to expand to a national launch of our lead product, an FDA-approved therapeutic for amblyopia that allows patients to watch TV as treatment instead of wearing a patch.

[Alleviant Medical @alleviant]

Alleviant closes $75M in financing to support pivotal trial, led by @S3ventures and @RiverVest
#medtech #heartfailure #hfpef
https://t.co/UfhUVwvAil